Relapsed / Refractory Myelodysplastic Syndromes (1)

Not yet recruiting (1)

early phase 1 (1)

Nuwacell Biotechnologies Co., Ltd. (1)

The First Affiliated Hospital of University of Science and Technology of China (1)

ncr300 (1)

drug (1)

Industry (1)

Interventional (1)

ncr300

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

May 7, 2022